loader image
Sunday, December 21, 2025
87.1 F
McAllen
- Advertisement -

Therapy Cat Brings Smiles to Patients at DHR Health

Translate to Spanish or other 102 languages!

Zane Grey, a 5-year-old rescued Maine Coon with Therapy Animals of San Antonio, made a special visit to DHR Health in Edinburg, Texas this week with his handler Beverly Oakes. The pair travel across the state on a volunteer basis bringing people and animals together for healing.
Zane Grey, a 5-year-old rescued Maine Coon with Therapy Animals of San Antonio, made a special visit to DHR Health in Edinburg, Texas this week with his handler Beverly Oakes. The pair travel across the state on a volunteer basis bringing people and animals together for healing.

Mega Doctor News

- Advertisement -

Edinburg, TX – Zane Grey, a 5-year-old rescued Maine Coon with Therapy Animals of San Antonio, made a special visit to DHR Health in Edinburg, Texas this week with his handler Beverly Oakes. The pair travel across the state on a volunteer basis bringing people and animals together for healing.

On Monday, January 31st, Zane Grey, a certified therapy cat, visited medical staff and pediatric patients at DHR Health.

That’s where the real magic happened. Toddlers and teens were quick to pet and snuggle the therapy cat, and were delighted to have such a sweet, furry friend at their bedside.

- Advertisement -

Zane and Beverly then visited the DHR Health Rehabilitation Hospital on Tuesday where patients received some of Zane’s healing purr powers. Therapy cats are relied on for emotional support, to provide comfort to those dealing with disabilities, disorders or who are in particular need of companion support.

DHR Health would like to thank Beverly Oakes, Zane Grey, and Therapy Animals of San Antonio for their visit. The volunteer non-profit organization not only provides visits to hospitals and other facilities, but they take part in educational presentations and crisis situations. 

To learn more about them, or to donate, visit therapyanimalssa.org

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×